-
Atrial fibrillation remains a common and vexing problem after cardiac surgery.
-
In a well-designed double-blind placebo-controlled clinical trial in COPD patients admitted with an exacerbation, aminophylline produced no clinically relevant benefit but increased the incidence of nausea.
-
In daily clinical practice, OAC was only given to a minority (30%) of AMI patients with AF, despite the fact that OAC was associated with a 29% relative and 7% absolute reduction in 1-year mortality ...
-
This case series and prospective observational study describe propylene glycol toxicity in patients receiving IV benzodiazepines.
-
Rare cases of fatal toxic shock syndrome associated with Clostridium sordellii have been reported; clinicians are urged to be aware of warning signals.
-
eventy-six patients with diabetic foot osteomyelitis underwent surgical bone biopsy for culture had bone culture results compared to swab culture results.
-
In ACS patients without persistent ST-segment elevation, there is a strong, consistent, temporal, and dose-related association between bleeding and death.
-
The 2006 guidelines for the management of patients with atrial fibrillation clarify previous recommendations for anticoagulation to prevent other thromboembolic events.
-
Aspiration of oropharyngeal secretions is considered one of the mechanisms of development of VAP. In this randomized trial of two oral decontamination medications, the authors show a significant reduction in the incidence of VAP.
-
Both nitazoxanide and the investigational anionic polymer, tolevamer, may have efficacy comparable to that of standard therapies in the treatment of CDAD. The addition of rifampin to metronidazole is not superior to treatment with metronidazole alone.